Research Topic

Viral Infection, Tumor Development and Host Immune Response

About this Research Topic

Infectious pathogens, in particular viruses including Epstein-Barr virus (EBV), hepatitis B and C viruses (HBV and HCV), human papilloma virus (HPV), among others, play a significant role in the development of human cancers, accounting for 20% of cancer cases worldwide, in which EBV, HBV and HCV, and HPV cause nasopharyngeal cancer, liver cancer, and cervical cancer, respectively. Not only can viral infection stimulate host immune responses to induce acute hyperinflammation and cause tissue damage, but it also influences tumor initiation and progression over a wide variety of ways, such as induction of genomic instability, metabolic reprogramming, chronic activation of inflammation, and alteration of tumor microenvironment.

In this Research Topic, we focus on understanding of the link between viral infection, tumor development and host immune response. The aim is to collect original research on cellular and molecular mechanism for viral infection-induced diseases with particular interest in host immune response and tumorigenesis as well as original studies related to biomedical applications including accurate diagnosis, precise prevention, and precise treatment.

We welcome the submission of original research papers, as well as reviews, research reports or specific comments on recently published articles including but not limited to:
• Preclinical research that furthers our understanding of the mechanisms underlying viruses stimulate or evade immune response, and microbe infection in tumorigenesis as well as molecular mechanisms of drug resistance.
• Translational research by focusing on identification of new drugs and new approaches for the development of diagnostic and therapeutic modalities for infectious diseases and cancer.
• Clinical studies informing diagnosis, treatment, and vaccine prevention for viral infection and the related cancer diseases.


Keywords: viral infection, inflammation, cancer, immune response, precise prevention and precise treatment


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Infectious pathogens, in particular viruses including Epstein-Barr virus (EBV), hepatitis B and C viruses (HBV and HCV), human papilloma virus (HPV), among others, play a significant role in the development of human cancers, accounting for 20% of cancer cases worldwide, in which EBV, HBV and HCV, and HPV cause nasopharyngeal cancer, liver cancer, and cervical cancer, respectively. Not only can viral infection stimulate host immune responses to induce acute hyperinflammation and cause tissue damage, but it also influences tumor initiation and progression over a wide variety of ways, such as induction of genomic instability, metabolic reprogramming, chronic activation of inflammation, and alteration of tumor microenvironment.

In this Research Topic, we focus on understanding of the link between viral infection, tumor development and host immune response. The aim is to collect original research on cellular and molecular mechanism for viral infection-induced diseases with particular interest in host immune response and tumorigenesis as well as original studies related to biomedical applications including accurate diagnosis, precise prevention, and precise treatment.

We welcome the submission of original research papers, as well as reviews, research reports or specific comments on recently published articles including but not limited to:
• Preclinical research that furthers our understanding of the mechanisms underlying viruses stimulate or evade immune response, and microbe infection in tumorigenesis as well as molecular mechanisms of drug resistance.
• Translational research by focusing on identification of new drugs and new approaches for the development of diagnostic and therapeutic modalities for infectious diseases and cancer.
• Clinical studies informing diagnosis, treatment, and vaccine prevention for viral infection and the related cancer diseases.


Keywords: viral infection, inflammation, cancer, immune response, precise prevention and precise treatment


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

31 December 2021 Abstract
31 May 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

31 December 2021 Abstract
31 May 2022 Manuscript

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..